1. A therapeutic composition that contains one or more polyphenols and two or more carotenoids, which are selected from the group consisting of lutein, lycopene and β-carotene. The therapeutic composition according to claim 1, wherein one or more polyphenols is selected from the group consisting of carnosic acid, quercetin, resveratrol, gallic acid, chicorye acid, gingerol and curcumin. The therapeutic composition of claim 2, wherein the polyphenol is carnosic acid. The therapeutic composition of claim 2, wherein the polyphenol is quercetin. The therapeutic composition of claim 2, wherein the polyphenol is resveratrol. The therapeutic composition of claim 2, wherein the polyphenol is gallic acid. The therapeutic composition according to claim 2, which essentially consists of lycopene, lutein and carnosic acid. The therapeutic composition according to claim 2, which essentially consists of lutein, β-carotene and carnosic acid. The therapeutic composition according to claim 2, which essentially consists of lycopene, β-carotene and carnosic acid. The therapeutic composition according to any one of claims 7 to 9, wherein said composition further comprises phytoen. 11. The therapeutic composition according to any one of claims 7 to 9, wherein said composition further comprises phytofluen. The therapeutic composition according to any one of claims 7 to 9, wherein said composition further comprises phytoen and phytofluen. A method of inhibiting or reducing the formation of superoxide ions, NO, TNF-α and / or PGEy of a mammalian subject, which comprises administering to the subject a therapeutic composition according to any one of claims 1-12.14. A method for the treatment of pathological conditions in which superoxide ions, NO, TNF-α and / or PGE perform1. Терапевтическая композиция, которая содержит один или несколько полифенолов и два или более каротиноидов, которые выбирают из группы, состоящей из лютеина, ликопена и β-каротина.2. Терапевтическая композиция по п.1, где
